A recent study, however, found that SNCA (α-synuclein) mRNA is not increased in sporadic Parkinson’s disease, and α-synuclein accumulation does not block GDNF signalling in either Parkinson’s disease or Parkinson’s disease models (Su et al., 2017). This evidence concerns the gene SNCA and Parkinson disease.